Patents by Inventor Lars Ole Haustedt

Lars Ole Haustedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11820756
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: November 21, 2023
    Assignee: PHARVARIS NETHERLANDS B.V.
    Inventors: Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt
  • Patent number: 11540539
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste or enhance the perception of salty taste of a salt. Food products may include such salty compounds, which may be used to reduce the sodium content, while parting a similar level of saltiness.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: January 3, 2023
    Assignee: General Mills, Inc.
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Michael Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Publication number: 20220289730
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to said compound(s) for use as in a method of treating a skin disorder; eye disease; ear disease; mouth, throat and respiratory disease; gastrointestinal disease; liver, gallbladder and pancreatic disease; urinary tract and kidney disease; disease of male genitale organs and female genitale organs; disease of the hormone system; metabolic disease; cardiovascular disease; blood disease; lymphatic disease; disorder of the central nervous system; brain disorder; musculoskeletal system disease; allergy disorder; pain; infectious disease; inflammatory disorder; injury; immunology disorder; cancer; hereditary disease; or edema.
    Type: Application
    Filed: May 25, 2020
    Publication date: September 15, 2022
    Inventors: Christoph GIBSON, Joern SAUPE, Horst-Dieter AMBROSI, Lars Ole HAUSTEDT
  • Publication number: 20220135543
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Application
    Filed: January 18, 2022
    Publication date: May 5, 2022
    Inventors: Christoph GIBSON, Joern SAUPE, Horst-Dieter AMBROSI, Lars Ole HAUSTEDT
  • Patent number: 11261173
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: March 1, 2022
    Assignee: PHARVARIS NETHERLANDS B.V.
    Inventors: Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt
  • Publication number: 20210017158
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Christoph GIBSON, Joern SAUPE, Horst-Dieter AMBROSI, Lars Ole HAUSTEDT
  • Patent number: 10836748
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: November 17, 2020
    Assignee: Pharvaris Netherlands B.V.
    Inventors: Christoph Gibson, Joern Saupe, Horst-Dieter Ambrosi, Lars Ole Haustedt
  • Publication number: 20200281236
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste, enhance the perception of salty taste of a salt, or act at one or more sodium channels. Food products may include such naturally-derived compounds, which may be used to reduce the sodium content, while imparting a similar level of saltiness.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 10, 2020
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Michael Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Publication number: 20200255405
    Abstract: The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.
    Type: Application
    Filed: April 28, 2020
    Publication date: August 13, 2020
    Inventors: Christoph GIBSON, Joern SAUPE, Horst-Dieter AMBROSI, Lars Ole HAUSTEDT
  • Publication number: 20190090520
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste, enhance the perception of salty taste of a salt, or act at one or more sodium channels. Food products may include such naturally-derived compounds, which may be used to reduce the sodium content, while imparting a similar level of saltiness.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Michael Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Patent number: 10159268
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste, enhance the perception of salty taste of a salt, or act at one or more sodium channels. Food products may include such naturally-derived compounds, which may be used to reduce the sodium content, while imparting a similar level of saltiness.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: December 25, 2018
    Assignee: GENERAL MILLS, INC.
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Micheal Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Publication number: 20160008297
    Abstract: The present invention primarily relates to the use of one or more specific compounds and/or one or more respective salt(s) thereof for preventing, reducing or alleviating itchy skin condition(s), and/or as PAR-2 antagonist. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, in particular for preventing, reducing or alleviating one or more itchy skin conditions and/or for providing a PAR-2 antagonistic effect, comprising or consisting of an effect amount of such compound(s) and/or salt(s) and one or more cosmetically and/or pharmaceutically acceptable carriers.
    Type: Application
    Filed: August 23, 2012
    Publication date: January 14, 2016
    Applicant: B.R.A.I.N. Biotechnology Research And Information Network AG
    Inventors: Gerhard SCHMAUS, Michael KROHN, Dirk SOMBROEK, Lars Ole HAUSTEDT, Grit KLUGE, Oskar KOCH, Antje KÖHLER
  • Publication number: 20150374658
    Abstract: The present invention relates to a composition comprising licoricidine and at least one component selected from the group consisting of glyasperin D, glyasperin C, gancaonin I and glycyrrhisoflavone, preferably wherein said composition is a Glycyrrhiza pallidiflora, Glycyrrhiza uralensis or Glycyrrhiza glabra extract, and to a method for preparing the same. Furthermore the present invention relates to pharmaceutical or cosmetic composition or a method for preparing the same, said pharmaceutical or cosmetic composition comprising licoricidine and at least one component selected from the group consisting of glyasperin D, glyasperin C, gancaonin I and glycyrrhisoflavone, wherein said composition is preferably a Glycyrrhiza pallidiflora, Glycyrrhiza uralensis or Glycyrrhiza glabra extract. Furthermore, the present invention relates to a pharmaceutical or cosmetic composition, as described above, for body and oral care, in particular for use as deodorant or for use in treating or preventing dental caries.
    Type: Application
    Filed: September 6, 2013
    Publication date: December 31, 2015
    Applicant: BRAIN AG - Biotechnology Research and Information Network AG
    Inventors: Michael Krohn, Jörg Mampel, Lars Ole Haustedt, Grit Kluge
  • Publication number: 20150374021
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste or enhance the perception of salty taste of a salt. Food products may include such salty compounds, which may be used to reduce the sodium content, while parting a similar level of saltiness.
    Type: Application
    Filed: February 7, 2014
    Publication date: December 31, 2015
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Micheal Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Publication number: 20150342233
    Abstract: Naturally-derived compounds having various structures elicit the perception of salty taste, enhance the perception of salty taste of a salt, or act at one or more sodium channels. Food products may include such naturally-derived compounds, which may be used to reduce the sodium content, while imparting a similar level of saltiness.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 3, 2015
    Inventors: Bernhard H. Van Lengerich, Olaf Gruess, Joachim Hans, Lars Ole Haustedt, Andreas Hochheimer, Micheal Krohn, Jens-Peter Muller, Christine M. Nowakowski, Suzanne Denise Pecore, Candace Michelle Rathjen-Nowak, Lia Scarabottolo, Karsten Siems
  • Publication number: 20150231045
    Abstract: The present invention relates to an anti-dandruff composition comprising 1-acetoxychavicol acetate (I). Furthermore, the present invention relates to a method for preparing said anti-dandruff composition and the use of said anti-dandruff composition for treating or preventing Malassezia induced dandruff formation. Moreover, the present invention relates to a method for preparing an Alpinia galanga extract and an extract obtainable or obtained by said method as well as the use of this extract for treating Malassezia induced dandruff formation comprising applying an anti-dandruff composition comprising said extract.
    Type: Application
    Filed: September 6, 2013
    Publication date: August 20, 2015
    Applicants: AnalytiCon Discovery GmbH, BRAIN AG - Biotechnology Research and Information Network AG
    Inventors: Michael Krohn, Jörg Mampel, Lars Ole Haustedt, Grit Kluge
  • Publication number: 20140010939
    Abstract: The present invention relates to novel sweetness enhancer compounds of the formula (I), or a stereoisomer or a salt or a hydrate thereof, to the use of a compound of formula (I) or a stereoisomer or a salt or a hydrate thereof as a sweetness enhancer, to sweetener compositions comprising at least one sweetener and a compound of formula (I) or a stereoisomer or a salt or a hydrate thereof, to a method for the manufacture of a compound of formula (I) or a stereoisomer or a salt or a hydrate thereof, to methods of making the sweetener compositions and to tabletop sweetener compositions comprising a compound of formula (I) or a stereoisomer or a salt or a hydrate thereof. Further, the invention relates to consumables comprising a consumable product and a compound of formula (I) or a stereoisomer or a salt or a hydrate thereof.
    Type: Application
    Filed: February 7, 2012
    Publication date: January 9, 2014
    Applicant: Nutrinova Nutrition Specialties & Food Ingredients GmbH
    Inventors: Michael Krohn, Simon Seibert, Alice Kleber, Johann Wonschik, Karsten Siems, Jens-Peter Muller, Lars Ole Haustedt, Oliver Schwarz